Brief: N4 Pharma Proposes Name Change To Thalia Therapeutics
Feb 27 (Reuters) - N4 Pharma PLC N4P.L: N4 PHARMA PLC - PROPOSES NAME CHANGE TO THALIA THERAPEUTICS Source text: ID:nRSa6034Ua Further company coverage: N4P.L (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results